BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 26138037)

  • 21. Detection of carbonic anhydrase IX protein in the diagnosis of malignant pleural effusion by enzyme-linked immunosorbent assay and immunocytochemistry.
    Liao ND; Lee WY
    Cancer Cytopathol; 2012 Aug; 120(4):269-75. PubMed ID: 22367930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
    Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
    Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
    Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
    Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma.
    Yang JS; Lin CW; Chuang CY; Su SC; Lin SH; Yang SF
    Tumour Biol; 2015 Dec; 36(12):9517-24. PubMed ID: 26130414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma.
    Yang JS; Chen MK; Yang SF; Chang YC; Su SC; Chiou HL; Chien MH; Lin CW
    Clin Chem Lab Med; 2014 Sep; 52(9):1367-77. PubMed ID: 24695043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma.
    Eckert AW; Horter S; Bethmann D; Kotrba J; Kaune T; Rot S; Bache M; Bilkenroth U; Reich W; Greither T; Wickenhauser C; Vordermark D; Taubert H; Kappler M
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.
    Bui MH; Visapaa H; Seligson D; Kim H; Han KR; Huang Y; Horvath S; Stanbridge EJ; Palotie A; Figlin RA; Belldegrun AS
    J Urol; 2004 Jun; 171(6 Pt 1):2461-6. PubMed ID: 15126876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum carbonic anhydrase IX during first-line therapy of ovarian cancer.
    Woelber L; Mueller V; Eulenburg C; Schwarz J; Carney W; Jaenicke F; Milde-Langosch K; Mahner S
    Gynecol Oncol; 2010 May; 117(2):183-8. PubMed ID: 20051287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
    Capkova L; Koubkova L; Kodet R
    Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer.
    Schütze D; Milde-Langosch K; Witzel I; Rody A; Karn T; Schmidt M; Choschzick M; Jänicke F; Müller V
    J Cancer Res Clin Oncol; 2013 May; 139(5):747-54. PubMed ID: 23358720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer.
    Choschzick M; Oosterwijk E; Müller V; Woelber L; Simon R; Moch H; Tennstedt P
    Virchows Arch; 2011 Aug; 459(2):193-200. PubMed ID: 21691815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
    Generali D; Fox SB; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield SM; Bruzzi P; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Bottini A; Harris AL
    Endocr Relat Cancer; 2006 Sep; 13(3):921-30. PubMed ID: 16954440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples.
    Zhou BF; Wei JH; Chen ZH; Dong P; Lai YR; Fang Y; Jiang HM; Lu J; Zhou FJ; Xie D; Luo JH; Chen W
    Oncotarget; 2016 Jul; 7(27):41703-41714. PubMed ID: 27203388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
    Allory Y; Beukers W; Sagrera A; Flández M; Marqués M; Márquez M; van der Keur KA; Dyrskjot L; Lurkin I; Vermeij M; Carrato A; Lloreta J; Lorente JA; Carrillo-de Santa Pau E; Masius RG; Kogevinas M; Steyerberg EW; van Tilborg AA; Abas C; Orntoft TF; Zuiverloon TC; Malats N; Zwarthoff EC; Real FX
    Eur Urol; 2014 Feb; 65(2):360-6. PubMed ID: 24018021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma.
    Brockton NT; Klimowicz AC; Bose P; Petrillo SK; Konno M; Rudmik L; Dean M; Nakoneshny SC; Matthews TW; Chandarana S; Lau HY; Magliocco AM; Dort JC
    Oral Oncol; 2012 Jul; 48(7):615-22. PubMed ID: 22366443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
    van Kessel KE; Beukers W; Lurkin I; Ziel-van der Made A; van der Keur KA; Boormans JL; Dyrskjøt L; Márquez M; Ørntoft TF; Real FX; Segersten U; Malats N; Malmström PU; Van Criekinge W; Zwarthoff EC
    J Urol; 2017 Mar; 197(3 Pt 1):590-595. PubMed ID: 27746284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma.
    Gkialas I; Papadopoulos G; Iordanidou L; Stathouros G; Tzavara C; Gregorakis A; Lykourinas M
    Urology; 2008 Nov; 72(5):1159-63. PubMed ID: 18514770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.